TrialBlood advances2019
Long-term remissions after stopping pembrolizumab for relapsed or refractory multiple myeloma.
Ashraf Z Badros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
TrialBlood advances2019
Ashraf Z Badros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.